3-Hydroxyanthranilic Acid (CID 86) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(36)
 
 
Inactive(392)
 
 
Inconclusive(5)
 
 
Unspecified(40)
 
 
Top Targets:
7TM GPCR Srx(9)
 
 
 
6PGL(5)
 
 
 
7TM GPCR Srsx(5)
 
 
TRP 2(5)
 
 
Peptidase C48(4)
 
 
BioAssay Types:
Screening(315)
 
 
 
Confirmatory(79)
 
 
 
 
 
Literature(69)
 
 
 
 
BioActivity Types:
Potency(52)
 
 
 
 
 
IC50(19)
 
 
 
 
EC50(4)
 
 
 
AC50(2)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 473    Data Row: 473   Total Pages: 10   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID47193877]
IC50 1.44Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504765, Type: confirmatory]glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848]
View
2
[SID47193877]
EC50 5.43Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity [AID435010, Type: confirmatory]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
3
[SID47193877]
EC50 6.102Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation [AID434968, Type: confirmatory]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
4
[SID47193877]
IC50 7.18A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen [AID2501, Type: confirmatory]
View
5
[SID47193877]
IC50 20.09Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents [AID1903, Type: confirmatory]large T antigen [Simian virus 40] [gi:297591903]
View
6
[SID47193877]
AC50 27.17Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Non-Covalent Inhibitors of RecA-Intein Splicing Activity [AID449750, Type: confirmatory]replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200]
View
7
[SID47193877]
Potency 39.8107qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory]DNA polymerase iota [Homo sapiens] [gi:154350220]
View
8
[SID47193877]
Potency 39.8107qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory]DNA polymerase iota [Homo sapiens] [gi:154350220]
View
9
[SID47193877]
IC50 40.9Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase [AID540269, Type: confirmatory]glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848]
View
10
[SID47193877]
Potency 56.2341qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory]Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054]
View
11
[SID47193877]
 uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening]glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848]
View
12
[SID47193877]
 Single concentration confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504753, Type: screening]glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848]
View
13
[SID46393285]
 Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature]Chain A, Structure And Function Of Phenazine-biosynthesis Protein Phzf From Pseudomonas Fluorescens [gi:56554120]
View
14
[SID47193877]
 Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening]putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066]
View
15
[SID47193877]
 Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening]
View
16
[SID47193877]
 uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening]Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397]
View
17
[SID103583212]
 Inhibition of TCR-mediated NF-kappaB activation in transgenic BALB/c mouse TH2 cells at 100 uM by EMSA [AID385961, Type: Literature]
View
18
[SID103583212]
 Inhibition of TCR-mediated NF-kappaB activation in human Jurkat cells at 100 uM by EMSA [AID385965, Type: Literature]
View
19
[SID103583212]
 Inhibition of CD28-induced NF-kappaB activation in human Jurkat cells by EMSA [AID385980, Type: Literature]
View
20
[SID103583212]
 Inhibition of CD3/CD28-induced NF-kappaB activation in human Jurkat cells by EMSA [AID385981, Type: Literature]
View
21
[SID103583212]
 Inhibition of PDK1 phosphorylation in human Jurkat cells by western blotting [AID385982, Type: Literature]
View
22
[SID103583212]
 Inhibition of PDK1 phosphorylation in transgenic BALB/c mouse TH2 cells by western blotting [AID385983, Type: Literature]
View
23
[SID103583212]
 Induction of apoptosis in transgenic TH1 cells after 48 hrs by FACS [AID385989, Type: Literature]
View
24
[SID103583212]
 Antiproliferative activity in transgenic BALB/c mouse TH2 cells assessed as [3H]thymidine incorporation after 30 mins [AID386006, Type: Literature]
View
25
[SID103583212]
 Induction of apoptosis in transgenic BALB/c mouse TH2 cells after 48 hrs by FACS [AID386007, Type: Literature]
View
26
[SID103583212]
 Induction of apoptosis in human human Jurkat cells after 48 hrs by FACS [AID386008, Type: Literature]
View
27
[SID103583212]
 Antiasthmatic activity in ovalbumin-challenged BALB/c mouse assessed as reduction in airway hyperresponsiveness at 100 ug, intratracheally administered 4 hrs after challenge [AID386010, Type: Literature]
View
28
[SID103583212]
 Antiasthmatic activity in ovalbumin-challenged BALB/c mouse assessed as reduction in airway resistance at 100 ug, intratracheally administered 4 hrs after challenge [AID386213, Type: Literature]
View
29
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in peribronchial eosinophil infiltration in bronchoalveolar lavage fluid [AID386217, Type: Literature]
View
30
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in perivascular eosinophil infiltration in bronchoalveolar lavage fluid [AID386218, Type: Literature]
View
31
[SID103583212]
 Induction of apoptosis in ovalbumin-challenged transgenic BALB/c mouse TH2 cells transfected in SCID mouse assessed as decrease in viable cell in lungs [AID386231, Type: Literature]
View
32
[SID47193877]
 FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening]orexin receptor type 1 [Homo sapiens] [gi:222080095]
View
33
[SID47193877]
 FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening]orexin receptor type 1 [Homo sapiens] [gi:222080095]
View
34
[SID47193877]
 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening]platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099]
View
35
[SID47193877]
 Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity [AID2221, Type: screening]DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874]
View
36
[SID47193877]
 Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening]Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504]
View
37
[SID47193877]
 Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID651616, Type: screening]Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504]
View
38
[SID47193877]
 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening]glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484]
View
39
[SID47193877]
 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening]glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484]
View
40
[SID47193877]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
41
[SID47193877]
Potency qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory]acid sphingomyelinase [Homo sapiens] [gi:179095]
View
42
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 100 ug [AID386219, Type: Literature]
View
43
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 100 ug by ELISA [AID386220, Type: Literature]
View
44
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 100 ug by ELISA [AID386221, Type: Literature]
View
45
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 25 ug [AID386222, Type: Literature]
View
46
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 25 ug by ELISA [AID386223, Type: Literature]
View
47
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 25 ug by ELISA [AID386224, Type: Literature]
View
48
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in eosinophil infiltration in bronchoalveolar lavage fluid at 6 ug [AID386225, Type: Literature]
View
49
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL5 level in bronchoalveolar lavage fluid at 6 ug by ELISA [AID386226, Type: Literature]
View
50
[SID103583212]
 Antiasthmatic effect in ovalbumin-challenged BALB/c mouse assessed as decrease in IL13 level in bronchoalveolar lavage fluid at 6 ug by ELISA [AID386227, Type: Literature]
View